Keywords: Molecular Imaging, Cell Tracking & Reporter Genes
Motivation: A non-invasive imaging technology for monitoring cell survival and in-vivo migration after transplantation is critical to optimizing and translating stem cell-based therapies.
Goal(s): To extend our previously reported bright-ferritin cell tracking platform to monitoring stem cell therapy, we investigated tracking human neural progenitor cells transplanted in the rat spinal cord.
Approach: In-vitro assays of proliferation and differentiation, and imaging both in vitro on cell pellets and in vivo in rats were performed.
Results: Monitoring rats on MRI over seven weeks confirmed the ability to assess cell retention and distribution in the rat spinal cord.
Impact: Our bright-ferritin platform demonstrated no adverse effects on human neural progenitor cells. Stem cells injected in the rat spinal cord could be tracked longitudinally and on-demand via a bright T1-contrast on MRI.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords